Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy

NCT03249727 is registered in ClinicalTrials.gov with ATGen Canada Inc as lead sponsor.

NCT NCT03249727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03249727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy
Lead sponsor
ATGen Canada Inc
Phase
Not applicable
Overall status
Terminated
Start date
July 5, 2017
Completion date
October 11, 2018
Enrollment
396 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, immunity, innate